Skip to content

Public FDA record

Z-0480-2022: CovClear COVID-19 Rapid Antigen Test, ATG 900-031

Recall record Z-0480-2022 for Empowered Diagnostics LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0480-2022
Company in FDA record
Empowered Diagnostics LLC
FDA record creation date
Jan 29, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

COVID test kits were offered for sale and distributed to consumers in the United States without marketing approval, clearance, or authorization from FDA.

Source facts

Action
The firm notified their direct consignees by letter delivered by email on December 22, 2021. The letter explained the hazard and requested the discontinuation of use and distribution. Those who has further distributed the products, were requested to conduct a sub-recall.
Initiated
2021-12-22
Root cause
No Marketing Application
Distribution
US Nationwide Distribution
Recall number
Z-0480-2022
Recall status
Completed
CDRH record ID
191252
FDA record created
2022-01-29
Recall event number
89315

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗